|
Volumn 145, Issue 22, 2003, Pages 57-
|
SERM for early osteoporosis therapy. Risk for first spinal fracture reduced to half;SERM zur frühzeitigen Osteoporosetherapie. Risiko für erste Wirbelfraktur halbiert.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIESTROGEN;
PLACEBO;
RALOXIFENE;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
ARTICLE;
BREAST TUMOR;
CLINICAL TRIAL;
HUMAN;
INCIDENCE;
POSTMENOPAUSE OSTEOPOROSIS;
RISK;
SPINE FRACTURE;
TIME;
BREAST NEOPLASMS;
CLINICAL TRIALS;
ESTROGEN ANTAGONISTS;
HUMANS;
INCIDENCE;
OSTEOPOROSIS, POSTMENOPAUSAL;
PLACEBOS;
RALOXIFENE;
RISK;
SELECTIVE ESTROGEN RECEPTOR MODULATORS;
SPINAL FRACTURES;
TIME FACTORS;
|
EID: 85009047576
PISSN: 14383276
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (1)
|
References (0)
|